HCPCS Level II
J1455
Injection, foscarnet sodium, per 1000 mg
Codes near J1455
These sit next to J1455 in the CMS Level II file. All J codes
- J1450Injection fluconazole, 200 mg
- J1451Injection, fomepizole, 15 mg
- J1452Injection, fomivirsen sodium, intraocular, 1.65 mg
- J1453Injection, fosaprepitant, 1 mg
- J1454Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
- J1456Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
- J1457Injection, gallium nitrate, 1 mg
- J1458Injection, galsulfase, 1 mg
- J1459Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1460Injection, gamma globulin, intramuscular, 1 cc
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00143-9192-01 | Foscarnet Sodium | Hikma Pharmaceuticals USA Inc. | 60 |
| 25021-0189-84 | Foscarnet Sodium | Sagent Pharmaceuticals | 60 |
| 43066-0089-10 | Foscarnet Sodium | Baxter Healthcare Corporation | 60 |
| 63323-0875-50 | Foscarnet Sodium | FreseniUS Kabi USA, LLC | 6 |
| 70121-1744-02 | Foscarnet Sodium | Amneal Pharmaceuticals, LLC | 72 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.